• OPEN AN ACCOUNT
Indian Indices
Nifty
24,578.35 -346.35
(-1.39%)
Sensex
81,220.63 72.41
( 0.09%)
Bank Nifty
54,940.85 -442.00
( -0.80%)
Nifty IT
37,354.60 -927.95
( -2.42%)
Global Indices
Nasdaq
42,160.14 -270.96
(-0.64%)
Dow Jones
5,907.19 42.00
(0.72%)
Hang Seng
38,283.51 639.25
(1.70%)
Nikkei 225
8,602.92 -2.06
(-0.02%)
Forex
USD-INR
84.87 -0.55
(-0.64%)
EUR-INR
94.53 -1.49
(-1.55%)
GBP-INR
112.13 -1.43
(-1.26%)
JPY-INR
0.58 -0.01
(-2.04%)

EQUITY - MARKET SCREENER

Nath Bio-Genes (India) Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
537291
INE448G01010
341.3302463
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATHBIOGEN
7.76
322.69
EPS(TTM)
Face Value()
Div & Yield %
21.89
10
1.18
 

Nath Bio-Genes (India) consolidated net profit declines 43.51% in the March 2025 quarter
Apr 30,2025
Net profit of Nath Bio-Genes (India) declined 43.51% to Rs 1.48 crore in the quarter ended March 2025 as against Rs 2.62 crore during the previous quarter ended March 2024. Sales rose 20.75% to Rs 51.97 crore in the quarter ended March 2025 as against Rs 43.04 crore during the previous quarter ended March 2024.

For the full year,net profit declined 2.57% to Rs 38.60 crore in the year ended March 2025 as against Rs 39.62 crore during the previous year ended March 2024. Sales rose 9.71% to Rs 364.91 crore in the year ended March 2025 as against Rs 332.62 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales51.9743.04 21 364.91332.62 10
OPM %0.819.13 -13.6414.99 -
PBDT2.913.27 -11 43.8641.38 6
PBT1.572.28 -31 40.0438.11 5
NP1.482.62 -44 38.6039.62 -3